Bachrodt Amy bought MAZE
February 2, 2026 · Form 4 insider transaction
Bachrodt Amy bought 4,844 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $50.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,844
Price
$10.42
Total value
$50.5K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 2, 2026
Filing dateFebruary 4, 2026
Shares owned after17,809
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.